New framework aims to speed up tendon injury treatments using predictive biomarkers

Researchers have proposed combining biological therapies with blood or tissue biomarkers to better predict which tendon patients will recover successfully—and to design faster clinical trials. The approach could reduce treatment failures and accelerate approval of new therapies for injuries that sideline athletes and workers.

Originaltitel: Optimizing repair of tendon ruptures and chronic tendinopathies: Integrating the use of biomarkers with biological interventions to improve patient outcomes and clinical trial design